NASDAQ:SLNO

Soleno Therapeutics Stock Forecast

etoro logo Buy SLNO
*Your capital is at risk
$53.01
+0 (+0%)
At Close: Jul 06, 2026
Add SLNO to Watchlist?
Some Reasons Why To Add SLNO:
  • Lower volatility than the market (beta -2.22)
  • High gross margin of 98.6%
  • Excellent financial health (Piotroski 7/9)

SLNO Performance

FAQ

What is the symbol for Soleno Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Soleno Therapeutics Inc is SLNO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Soleno Therapeutics Inc Stock?
Soleno Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Soleno Therapeutics Inc Stock?
Soleno Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Soleno Therapeutics Inc Stock.

What's the current price of Soleno Therapeutics Inc Stock?
As of the end of day on the Jul 06, 2026, the price of an Soleno Therapeutics Inc (SLNO) share was $53.01.

What is the 52-week high and low for Soleno Therapeutics Inc Stock?
The 52-week high for Soleno Therapeutics Inc Stock is $90.15 and the 52-week low is $29.47.

What is the market capitalization of Soleno Therapeutics Inc Stock?
As of the Jul 06, 2026, the market capitalization of Soleno Therapeutics Inc is 2.763B.

When is the next earnings date for Soleno Therapeutics Inc?
The upcoming earnings date for Soleno Therapeutics Inc is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT SOLENO THERAPEUTICS INC
Soleno Therapeutics
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its n...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
12.69% Jun 29
OSIS
$218.29
1.16% Jun 26
NMRK
$15.02
3.86% Jun 24
TTEK
$28.04
11.09% Jun 23
NESR
$25.07
10.21% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE